CME Group Inc. (NASDAQ: CME) and Morningstar Inc. (NASDAQ: MORN) entered into a multi-year licensing agreement that allows CME Group to launch derivatives products based on Morningstar equity index benchmarks, the companies announced June 10.

The exclusive agreement covers derivatives on Morningstar US Total Market, Large Cap, Large Cap Value, Large Cap Growth, Mid Cap, and Small Cap Indexes. These indexes underpin more than $3 trillion in linked assets, according to the companies.

CME Group will offer derivatives on the Morningstar Market Indexes for the first time through this partnership. The indexes are currently rebranding from CRSP following Morningstar's acquisition of CRSP earlier in 2026.

"We are pleased to partner with Morningstar to help unlock more precise, next-generation risk management tools for the global investment community," said Tim McCourt, CME Group Senior Managing Director and Global Head of Equities, FX and Alternative Products.

Amelia Furr, president of Morningstar Indexes, said the collaboration will "bring our high-quality equity indexes to an entirely new segment of the global investment marketplace." She noted that Morningstar became a provider of U.S. equity benchmarks through its CRSP acquisition.

CME Group operates derivatives exchanges across multiple asset classes including interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The company trades through its CME Globex platform and operates CME Clearing.

Morningstar provides investment insights across North America, Europe, Australia, and Asia, with approximately $370 billion in assets under management and advisement as of March 31, 2026. The company operates through subsidiaries in 32 countries.